In Re-Thinking Eating Disorders: Language, Emotion, and the Brain, Barbara Pearlman integrates ideas from psychoanalysis, developmental psychology and cutting-edge neuroscience to produce a model of neural emotional processing which may underpin the development of an eating disorder.Based on clinical observations over 30 years, this book explores how state change from symbolic to concrete thinking may be a key event that precedes an eating disorder episode. The book introduces this theory, and offers clinicians working with these challenging clients an entirely new model for treatment: internal language enhancement therapy (ILET). This easily teachable therapy is explored throughout the book with case studies and detailed descriptions of therapeutic techniques. Re-Thinking Eating Disorders will appeal to students and practitioners working with this clinical group who are seeking an up-to-date and integrative approach to therapy.
Barbara Pearlman, Consultant Clinical Psychologist, is an Honorary Fellow at the Centre for Clinical Neuropsychology Research, University of Exeter. In 2010, she was awarded a PhD for her theoretical work on the neurobiology of how emotions and language are processed in eating disorders, which lead to the creation of a new treatment: internal language enhancement therapy.
Table of Contents
Chapter 1 Introduction
Chapter 2 The Neurobiological Contribution to Understanding the Development of an Eating Disorder: Neurobiological Underpinnings of Eating Disorders
Chapter 3 A Conceptual Gap: Current Ideas in Eating Disorders and the Need for a New Treatment Approach
Chapter 4 Filling the Conceptual Gap: The Development of Symbolisation from a Developmental Neuropsychoanalytic Perspective
Chapter 5 Proposing A New Model of the Mind in Eating Disorders
Chapter 6 Theory and Practice
Chapter 7 The Problem With CBT
Chapter 8 ILET Therapy With 'Emily'
Chapter 9 Conclusions
A: Glossary of Abbreviated Terms
B: The ILET Protocol
C: History Template
D: Information for Patients
E: Emotional Events Questionnaire (EEQ)
F. Baseline Measurements Pre- and Post-Treatment
G. Measures for Randomised Clinical Trials of ILET versus Treatment as Usual, CBT and/or IPT